Contact Us at (480) 924-0006 • 3850 E Baseline Rd Building 1 Suite 102, Mesa, AZ 82506

Presentations as Late Breaking Clinical Trials

To the top

 

Moderate Pulmonary Embolism Treated with Thrombolysis: MOPETT Trial. Late Breaking Clinical Trial. ACC/i2 61st Annual Scientific Session, Chicago, IL, March 2011.

Endovenous Infra-Inguinal Stenting and Angioplasty in Deep

Venous Thrombosis Trial EVISTA-DVT Trial- Late Breaking Clinical Trial.  Society for Cardiac Angiography and Interventions, 24th  annual meeting. Baltimore, MD , May 2011.

Filter Implantation to Lower Thromboembolic Risk in Percutaneous Endovenous Intervention ( FILTER-PEVI Trial)- Late Breaking Clinical Trial ACC/i2 60th Annual Scientific Session, New Orleans, LA, April 2011.

TORPEDO Trial. Late Breaking Clinical Trial.TCT 2010. Washington D.C.

National & International Presentations

To the top

 

Target Specific Oral Anticoagulants Following Percutaneous Endovenous Intervention for Lower Extremity Deep Venous Thrombosis in Patients with Cancer. CVC, 6 Annual Meeting, July 2016, Chicago, IL.

DVT in the Patient with Concomitant Arterial Disease. CVC, 6 Annual Meeting, July 2016, Chicago, IL.

Advanced Interventional Techniques for DVT with Angiojet Zelante DVT and Penumbra. CVC, 6 Annual Meeting, July 2016, Chicago, IL.

Abdominal Aortic Endoluminal Grafts and Subsequent Laparascopic Abdominal Surgery Promotes Extensive Deep Vein Thrombosis. Society for Cardiac Angiography and Interventions, 29th  annual meeting, Orlando, Fl. May 2016.

Outcome of Life Star Stents in the Venous Circulation. Society for Cardiac Angiography and Interventions, 29th  annual meeting, Orlando, Fl. May 2016.

Treatment of Massive Pulmonary Embolism During Cardio- Pulmonary Collapse and Pulseless Electrical Activity With Low Dose Systemic Thrombolysis. Society for Vascular Medicine  27 Annual Meeting and Scientific Sessions, Long Beach, CA, June 2016

Debate: PERT Teams Complicate the Care of Patients with PE. Society for Vascular Medicine  27 Annual Meeting and Scientific Sessions, Long Beach, CA, June 2016

Role Of Wallstents In The Treatment Of Chronic Inferior Vena Cava Filter Occlusion TCT October 2015, San Francisco CA.

New Oral Anticoagulants in Reduction of Post-Thrombotic Syndrome in Patients undergoing PEVI. New Cardiovascular Horizons, 16 Annual Meeting, New Orleans, LA, May 2015.

Treatment of Chronic Inferior Vena Cava Filter Occlusion with Wall Stents. Society for Cardiac Angiography and Interventions, 28th  annual meeting. San Diego, CA , May 2015.

The Year in Vascular Medicine: Venous Thromboembolism. Society for Vascular Medicine  26 Annual Meeting and Scientific Sessions, Baltimore, MD, June 2015.

Vascular Emergencies: Pulmonary Embolism. Society for Vascular Medicine  26 Annual Meeting and Scientific Sessions, Baltimore, MD, June 2015.

Role of Apixaban in Dialysis Patients after Percutaneous Endovenous Intervention for Deep Venous Thrombosis of the Lower Extremities, Society for Vascular Medicine  26 Annual Meeting and Scientific Sessions, Baltimore, MD, June 2015

The Use of New-Generation Anticoagulations in DVT & PE: What are the Current Indications? How to Address Negative Commercial Ads with Your Patient CVC, 5 Annual Meeting, July 2015, Chicago, IL.

Challenging Case Presentations with Expert Panel Discussion. CVC, 5 Annual Meeting, July 2015, Chicago, IL.

Percutaneous Endovenous Intervention in Cancer Patients with Deep Venous Thrombosis of the Lower Extremities. ACC/i2 64th Annual Scientific Session, San Diego, CA, March 2015.

Treatment of Pulmonary Embolism: Debates; ACC/i2 64th Annual Scientific Session, San Diego, CA, March 2015.

New Oral Anticoagulants in Cancer Patients Undergoing Percutaneous Endovenous Intervention for Lower Extremity Deep Venous Thrombosis, TCT 2014, Washington DC.

Endovascular Therapy or Anticoagulation for DVT: Results of the TORPEDO Trial, CVC 2014, Chicago, IL.

Laceration of Popliteal Vein Treated with Covered Stents. Society for Vascular Medicine 2014 Annual Meeting and Scientific Sessions, La Jolla , CA.

Paradigm shift in the treatment of PE:Updates on the MOPETT, PEITHO, TOPCOAT AND ULTIMA Trials.  Society for Vascular Medicine 2014 Annual Meeting and Scientific Sessions, La Jolla , CA.

Role of New Oral Anticoagulants in the Treatment of Superficial   Venous Thrombosis of the Lower Extremities. Society for Vascular Medicine 2014 Annual Meeting and Scientific Sessions, La Jolla , CA.

Anticoagulant and antiplatelet therapy cocktails after acute and chronic   DVT intervention – my current practice. Society for Cardiac Angiography  and Interventions, 27th  annual meeting. Las Vegas, NV, May 2014.

Limited Role of Thrombectomy Devices Alone for Occlusive IVC Filter  Thrombosis.  Society for Cardiac Angiography and Interventions, 27th  annual meeting. Las Vegas, NV, May 2014.

Percutaneous Endovenous Intervention and New Oral Anticoagulants  Reduce  Post- Thrombotic Syndrome  in Acute Deep Venous  Thrombosis. Society for Cardiac Angiography and Interventions, 27th  annual meeting. Las Vegas, NV, May 2014.

Half dose Fibrinolysis in Pulmonary Embolism: Focus on MOPETT. ACC/i2 63rd Annual Scientific Session, Washington DC, March 2014.

Treatment of Heparin Induced Thrombocytopenia with New Oral Anticoagulants. ACC/i2 63rd Annual Scientific Session, Washington DC, March 2014.

Paradigm Shift in the Treatment of Pulmonary Embolism. ACC/i2 63rd Annual Scientific Session, Washington DC, March 2014.

Modern Management of DVT. iCON, Scottsdale, AZ, 2014. Role of Combination Medical Therapy With or Without Intervention in the Management of Acute PE.TCT 2013, San Francisco, CA.

Which Patients Should Have A Prophylactic IVC Filter Placed During Catheter Based Treatment Of Large Vein Clots: Based On A RCT – The Filter PEVI Study. VEITH Symposium, New York, NY 2013.
Role of Rivaroxaban in the Treatment of Venous Thromboembolic Disease Associated With Cancer. ICCAD, Florence, Italy 2013.

Reduction of Hospitalization and Duration of Anticoagulation for Deep Venous Thrombosis in Patients Undergoing Percutaneous Endovenous Intervention and Receiving Novel Anticoagulants. TCT 2013, San Francisco, CA.

Argatroban and t-PA During Catheter-Directed thrombolysis for Extensive lower Extremity Deep Venous Thrombosis. TCT 2013, San Francisco, CA.

Utilization of Cleaner Device for Thrombectomy of Upper Extremity Deep Venous Thrombosis.TCT 2013, San Francisco, CA.

IVC Filters: Current indications and retrieval. New Cardiovascular Horizons, New Orleans, LA, June 2013.

Deep Venous Thrombosis: Diagnosis & Management Considerations. New Cardiovascular Horizons, New Orleans, LA, June 2013.

Modern Medical Management of Venous thrombosis: New Drugs, New Strategies. Society for Cardiac Angiography and Interventions, 26th annual meeting. Orlando, Fl, May 2013.

Interventional Management for Iliofemoral Deep Venous Thrombosis ACC/i2 62nd Annual Scientific Session, San Francisco, CA, March 2013.

DVT: Medical Therapy versus Endovascular Therapy ACC/i2 62nd Annual Scientific Session, San Francisco, CA, March 2013.

Percutaneous Endovenous Intervention for DVT. iCON, Scottsdale, AZ, 2013.

Shorter Duration of Anticoagulation for Deep Venous Thrombosis in Patients Undergoing Percutaneous Endovenous Intervention and Receiving Rivaroxaban and Dabigatran. iCON, Scottsdale, AZ, 2013.

Role of Rivaroxaban in Patients Undergoing Percutaneous Endovenous Intervention for  Massive Lower Extremity Deep Venous Thrombosis. Society for Cardiac Angiography and Interventions, 26th annual meeting. Orlando, Fl, May 2013.

Treatment of Occlusive IVC Filter Thrombosis by Percutaneous Endovenous Intervention. Society for Cardiac Angiography and Interventions, 26th annual meeting. Orlando, Fl, May 2013.

Upper Extremity Venous Reconstruction for Chronic Venous Occlusive Disease. ISET, Miami, FL, January 2013.

Filter or No Filter for DVT Lysis? ISET, Miami, FL, January 2013.

Venous Stenting. ISET, Miami, FL, January 2013.

Synergistic Effects of Low Dose Argatroban and tPA During Catheter Directed Thrombolysis for Massive Iliac and Femoropopliteal Deep Vein Thrombosis. ISET, Miami, FL, January 2013.

Outcome of Stenting in the Subclavian Vein for Upper Extremity Edema.ISET, Miami, FL, January 2013.

Debate: Pro. Percutaneous Endovenous intervention with Emphasis on CDT for Acute Iliofemoral DVT. American College of Phlebology, 26 Annual Congress, Hollywood, Fl, November 15-18, 2012

Coumadin Resistance and Massive Bilateral DVT. American College of Phlebology, 26 Annual Congress, Hollywood, Fl, November 15-18, 2012

Percutaneous Endovenous Intervention for Occlusive IVC Filter Thrombosis. American College of Phlebology, 26 Annual Congress, Hollywood, Fl, November 15-18, 2012.

Role of Trellis Catheter in the Treatment of IVC Filter Thrombosis. TCT 2012, Miami, Fl, October 22-26, 2012.

Use of Dabigatran in Upper Extremity Deep Venous Thrombosis Following Percutaneous Endovenous Intervention. Society for Vascular Medicine 23rd Annual Scientific Sessions, June 2012 Minneapolis, MN.

IVC Filters: Types, Indications and retrieval. New Cardiovascular Horizons , New Orleans, LA, June 2012.

Role of IVC Filters in Endovenous Therapy for DVT. Fifth Razavi International Cardiovascular Surgery Congress. Mashhad, Iran,June 2012

Low Dose Argatroban and tPA in the Treatment of Massive Iliac and Femoropopliteal Deep Vein Thrombosis. Society for Cardiac Angiography and Interventions, 25th annual meeting. Las Vegas, NV, May 2012.

Reduction in the Duration of Parenteral Anticoagulation for Deep Venous Thrombosis in Patients Undergoing Percutaneous Endovenous Intervention and Receiving Dabigatran. Society for Cardiac Angiography and Interventions, 25th annual meeting. Las Vegas, NV, May 2012.

Dabigatran in Deep Venous Thrombosis Refractory to Warfarin. ACC/i2 61st Annual Scientific Session, Chicago, IL, March 2011.

Debate- Con: Primary Stenting is the Treatment of Choice for Acute DVT. ACC/i2 61st Annual Scientific Session, Chicago, IL, March 2011.

Deep Venous Thrombosis: Optimal Patient Selection and techniques for Endovascular Interventions. ACC/i2 61st Annual Scientific Session, Chicago, IL, March 2011.

Percutaneous Endovenous Intervention for Upper Extremity Deep Venous Thrombosis. ISET, Miami, FL, January 2012.

Results of the Endovenous Infrainguinal Stenting Trial for DVT. TCT San Francisco, CA, November 2011.

Venous Disease in Podiatry. Desert Foot Conference, Phoenix, AZ, November 2011.

The TORPEDO Trial. New Cardiovascular Horizons, New Orleans, LA, June 2011.

Headaches Associated with Diseases of the Atrial Septum. The 15th Congress of the International Headache Society Berlin, Germany, June 2011.

Outcome of stenting in the Lower Extremity Venous Circulation for the Treatment of DVT. 21st World Society of Cardiothoracic surgery Berlin, Germany, June 2011.

Natural History of Venous Stents Implanted During Percutaneous Endovenous Intervention for Deep Venous Thrombosis. Society for Cardiac Angiography and Interventions, 24th annual meeting. Baltimore, MD , May 2011.

Role of Intravascular Ultrasound During Percutaneous Endovenous Intervention for Deep venous Thrombosis. Society for Cardiac Angiography and Interventions, 24th annual meeting. Baltimore, MD , May 2011.

Efficacy of Viabahn Stents in the Femoropopliteal Venous Segments in the Treatment of Deep Venous Thrombosis. ACC/i2 60th Annual Scientific Session, New Orleans, LA, April 2011.

Treatment of Massive Combined Subclavian and Jugular Vein Deep Venous Thrombosis by Percutaneous Endovenous Intervention. Case presentation. ACC/i2 60th Annual Scientific Session, New Orleans, LA, April 2011.

Peripheral Blood Gene Expression in Patients with and without Coronary Artery Disease. ACC/i2 60th Annual Scientific Session, New Orleans, LA, April 2011.

The “TORPEDO” Approach in the Treatment of Deep Venous Thrombosis. Cardiovascular Innovations. CRT, Washington DC, March 2011.

Very Low Bleeding Rates with Local Thrombolytic Therapy Given During Percutaneous Endovenous Intervention for the Treatment of Deep Venous Thrombosis. CRT, Washington DC, March 2011.

Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion- Oral presentation-24 Annual Congress, American College of Phlebology, Nov 6 2010 Orlando, FL.

Percutaneous Endovenous Intervention Reduces Post Thrombotic Syndrome and Recurrent Venous Thromboembolic Disease in Patients with Acute DVT. ACC/i2 59th Annual Scientific Session, Atlanta, Georgia, 2010.

Low Restenosis Rate of Stents Placed in Peripheral Venous Circulation. Society for Cardiac Angiography and Interventions 23rd annual meeting. San Diego, CA, May 2010.

Determination of the Appropriate Transcatheter Endovenous Tissue Plasminogen Activator Dose for the Treatment of Extensive Acute Proximal DVT. CRT 2010, Washington DC.

Power Pulse Spray and Angiojet Atherectomy in Massive Pulmonary Embolism. ISET 2010, Hollywood, Florida.

Differences in PFO Morphology in Patients with and without Neurologic Events. Society for Cardiac Angiography and Interventions 22nd annual meeting. Las Vegas, NV, June 2009.

Reduction of Post-Thrombotic Syndrome in Acute Deep Venous Thrombosis by Power Pulse Spray and Angiojet Thrombectomy. Society for Cardiac Angiography and Interventions. 22nd annual meeting. Las Vegas, NV, June 2009.

Incidental Pathologic findings on coronary and aortic multislice computed tomography. Society for Cardiac Angiography and Interventions 29th annual meeting. Chicago, IL , May 2006.

Treatment of migraines post ASD closure with clopidogrel. Society for Cardiac Angiography and Interventions 28th annual meeting, Ponte Vedra, FL, May 2005.

Evaluation of PAPVR prior to closure of interatrial shunts. SCA&I Society for Cardiac Angiography and Interventions 28th annual meeting, Ponte Vedra, FL, May 2005.

Reduction of Clinical Restenosis by Hyperbaric Oxygen Therapy.TCT 2003, Washington D.C. September 2003.

Hyperbaric Oxygen Therapy in Percutaneous Coronary Interventions: The Interim Results. Society for Cardiac Angiography and Interventions, 26th Annual Session, Boston, MA, May 2003.

Reduction of Restenosis in Percutaneous Coronary Interventions by Hyperbaric Oxygen Therapy ACC March 2003, Chicago, IL 2003.

Hyperbaric Oxygen Therapy: A Novel Strategy to Combat Restenosis.CRT 2003 Washington D.C. January 2003.

Hyperbaric Oxygen Therapy to Inhibit Restenosis in Percutaneous Coronary Interventions. Society for Cardiac Angiography and Interventions, 25th Annual Session, Seattle, WA May 2002.

Hyperbaric Oxygen Therapy Reduces Restenosis in Percutaneous Coronary Interventions. TCT 2002, Washington D.C. September 2002.


© 2013 Arizona Cardiovascular and Vein Clinic. All Rights Reserved. Website by Vein Catalyst.